References
- Kermani TA, Warrington KJ. Polymyalgia rheumatica. Lancet 2013;5:63–72.
- Barraclough K, Liddell WG, du Toit J, Foy C, Dasgupta B, Thomas M, et al. Polymyalgia rheumatica in primary care: a cohort study of the diagnostic criteria and outcome. Fam Pract 2008;25:328–33.
- Helliwell T, Hider SL, Barraclough K, Dasgupta B, Mallen CD. Diagnosis and management of polymyalgia rheumatica. Br J Gen Pract 2012;62:275–6.
- Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012;71:484–92.
- Spiera R, Westhovens R. Provisional diagnostic criteria for polymyalgia rheumatica: moving beyond clinical intuition? Arthritis Rheum 2012;64:955–7.
- Martinez-Taboada VM, Alvarez L, RuizSoto M, Marin-Vidalled MJ, Lopez-Hoyos M. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 2008;44:207–20.
- Fragiadaki K, Tektoidou MG, Konsta M, Chrousos GP, Sfikakis PP. Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J Rheumatol 2012;37:60–2.
- Jordan KP, Clarke AM, Symmons DP, Fleming D, Porcheret M, Kadam U, et al. Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases. Br J Gen Pract 2007;57:7–14.
- Porcheret M, Hughes R, Evans D, Jordan K, Whitehurst T, Ogden H, et al. Data quality of general practice electronic health records: the impact of a program of assessments, feedback, and training. J Am Med Assoc 2004;11:78–86.
- White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980;48:817–30.
- Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 2006;65:1093–8.